Project will use big data and analytics to address pressing public health issue
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
Hello, again. Before we continue, we apologize for the long absence. We were meeting with some industry types yesterday afternoon and our session ran longer than expected. Now, though, we are in our usual groove and look forward to a productive day. It may be late August, but something is always happening...
Bristol-Myers Buys Rights To PDL BioPharma Drug (Associated Press)
Abbott Norvir Settlement Is Approved (Bloomberg News)
States Fight To Shield Docs From Data Mining (Associated Press)
